Abstract. A nationwide epidemiologic survey of familial Graves' disease (GD) was conducted in 2001. "Familial GD" was defined as a patient who had at least one Graves' patient within the proband's first-degree relatives. The primary survey was performed for estimating the prevalence of patients among a random selection of 2367 departments/hospitals of internal medicine, endocrinology, thyroidology and pediatrics. Of those receiving the primary questionnaire, 1361 (57.5%) responded, and 902 familial GD patients who visited them in 2000 were reported. The total number of patients was estimated to be 2850 (95% confidence intervals: 2100-3600). Based on the nationwide survey concerning the prevalence of hyperthyroidism in 1999, 2.1-3.1% of hyperthyroidism appeared to be familial GD and the relative risk of familial GD was roughly estimated to be 19-42. Subsequently, a second survey was carried out for obtaining the clinicoepidemiologic features of those patients. Of 902 patients, 487 (54%) were reported. No significant differences between familial and non-familial GD were found in age and sex distributions, clinical features or laboratory findings. Familial GD possessed the highest association with Hashimoto's thyroiditis, approximately 8% within the first-degree relatives, suggesting a shared genetic predisposition. These findings confirm the familial clustering of GD in the Japanese population, indicating the importance of environmental factors, genetic factors or both in the development of the disease.
GRAVES' disease (GD) is characterized by hyperthyroidism, goiter and ophthalmopathy, and is thought to be a complex disease caused by several genetic and environmental factors. Although numerous attempts have been made to elucidate the susceptibility genes of GD, the genetic basis still remains unclear, nor have the environmental factors of GD been precisely clarified.
Compiling epidemiologic data concerning familial clustering of diseases is useful for performing genetic studies. The relative risk of disease in siblings, the life-time risk for siblings divided by the population frequency of the disease, is often used as an estimation of the magnitude of the genetic contribution to disease [1] . If the risk of the disease is large, a genome scan to identify the susceptibility loci affecting the disease is warranted [2] . Nonetheless, there is no nationwide study concerning the family clustering of GD in Japan. In the present study, we aimed to clarify the prevalence of Japanese familial GD and to define the clinico-epidemiologic features by a nationwide survey.
Materials and Methods
A nationwide mail survey for familial GD was conducted in 2001 in Japan. The target patients were those who visited hospitals because of the disease in 2000. According to the Nationwide Epidemiologic Survey Manual issued by the Research Committee on Epidemiology of Intractable Disease, we selected four departments for the survey target: internal medicine, endocrinology, thyroidology, and pediatrics. The hospitals studied were selected randomly from a list of all hospitals in Japan. The selection rate was decided according to the stratification classified by the number of beds in the hospitals in Japan; the more beds a hospital had, the higher the probability it had of being selected. The selection rate was 100% for hospitals with more than or equal to 500 beds and university hospitals, whereas only 5% of hospitals with less than 100 beds were selected at random. Besides the two departments, we designated a department of endocrinology or thyroidology as a special department, and all of the special departments in Japan were selected as the study department. After the selection of the study departments/hospitals, we sent a questionnaire with diagnostic guidelines [3] . The primary survey asked only the numbers of patients with GD who had at least one Graves' patients within their first-degree relatives and had visited the hospital in 2000. If a department/ hospital responded that there was such a patient(s), the second mail survey questionnaire asking the detailed clinical features for each patient was sent. The present study was approved by the ethical committees of Okayama University School of Medicine and Juntendo University School of Medicine.
Considering the selection rate and the response rate to the survey, we estimated the total numbers of patients with familial GD as described previously [4, 5] . Ninety-five percent confidence intervals were calculated with an assumption of multinominal hypergeometric distribution. Age and sex distributions of the disease were estimated according to the data on the patients that were obtained by the second survey.
Results

Prevalence
For the primary survey, 2367 departments/hospitals of internal medicine, endocrinology/thyroidology and pediatrics were selected. Of them, 1361 (57.5%) responded and 902 familial GD patients were reported. The numbers of patients from department of pediatrics and other departments was 167 (18.5%) and 735 (71.5%), respectively. The total numbers of patients were estimated to be 2850 (95% confidence intervals: 2100-3600). The estimated number of patients with thyrotoxicosis who visited outpatient clinics in October of 1999 was 154,000, [6] . Since GD is the most common cause of thyrotoxicosis, ranging from 60-90% in different regions of the world including Japan [7] [8] [9] and the Japanese population in 1999 was estimated to be 126,686,000 [10] , the estimated number and frequency of GD patients was 92,400-138,600 and 0.073-0.11%. Therefore, the frequency of familial GD in GD and the relative risk of familial GD were roughly calculated to be 2.1-3.1% and 19-42, respectively (Table 1) .
Clinico-epidemiolgic features of familial GD
In the second survey, 487 (54%) of 902 patients were reported. Sex and age distributions are shown in Table 2 . The female/male ratio was 3.2 (360/114). Patients in their twenties to fifties were the most abundant, comprising 74% of the total. As shown in Table  3 , patients who had GD in parents, siblings and children were 49% (238/487), 40% (197/487) and 20% (98/487), respectively. Fourteen percent (69/487) had multiple GD members within the first-degree relatives and identical twins were found in 3% (17/487). The ratios of mother/father, sister/brother and daughter/son were 3.0 (180/60), 2.7 (152/57) and 4.6 (83/18), respectively. No significant gender-specificity was found in the disease transmission.
In the family history, HT was the most common, approximately 8% (22/282) of the patients who responded to the question whether they had HT within their first-degree relatives (Table 4) , while hypothyroidism with blocking-type TBII was seen only in 3 patients.
Other autoimmune diseases were seen in 15 patients, of which type 1 diabetes was most frequent (6 cases).
In complications of other diseases, approximately 10% of familial GD was associated with other autoimmune or allergic disorders (Table 5 ). Type 1 diabetes and atopic dermatitis were most common and each comprised 26% of the total. Concerning clinical manifestations, goiter and orbitopathy were present in 89% (413/475) and 34% (164/479), respectively (Table 6 ). Of patients with orbitopathy, diplopia was found in 10% (17/156) . Laboratory findings before treatment demonstrated that most patients exhibited increased serum free T4 and suppressed TSH levels, which are typical of hyperthyroidism ( Table 7 ). The activities of TSH binding inhibitor immunoglobulins (TBII) and antimicrosomal antibody tests (MCHA) measured by the hemagglutination assay were positive in 90% and 78%, respectively. Since the number of comments concerning other clinical manifestations and laboratory findings were small, they were not shown here.
Methylmercaptoimidazole (MMI) was more widely used than propylthiouracil (PTU) ( Table 8) . Approximately 20% of the patients were introduced into remission by administration of anti-thyroid drugs (ATD). The side effects of ATD, of which allergy was the most frequent, were found in approximately 20% of the patients. Radioisotope therapy and surgical operation were performed in 8% and 14%, respectively.
Discussion
This is the primary national report concerning familial GD in Japan. The prevalence of familial GD was estimated as 2.1-3.1% of hyperthyroidism and the relative risk of familial GD was roughly estimated to be 19-42. In Caucasians, the relative risks of familial GD GD/hyperthyroidism of the proband's first-degree relatives were reported as 16-26 [11] [12] [13] [14] . Since the latter included hyperthyroid disorders other than GD, one should be careful when comparing our results with theirs. Nonetheless, the Japanese relative risk estimated here was not so very different from that of the Caucasians. This finding indicates the familial clustering of GD, in particular the importance of environmental and/or genetic factors in the development of the disease. In fact, GD is thought to follow a nonMendelian pattern of inheritance under the influence of multiple genes and variable penetrance [11, 15] .
The age and sex distribution of familial GD did not appear to be significantly different from non-familial GD: patients in their twenties to fifties were the most abundant and a female-to-male preponderance was found in the proband's first-degree relatives. In the literature, there are conflicting findings concerning the distribution of GD among the probands' female relatives. Martin and Fisher [16] found that the proband's sisters were affected more than the mothers, but Evans et al. [12] and Stensky et al. [13] found the opposite tendency and an almost equal distribution, respectively. In the present study, the ratio of affected mother/ sister was 1.2 (180/152), which appeared to be almost equal. Regarding the gender-specificity of disease transmission, there are several reports that indicated gender-specific susceptibility in autoimmune thyroid diseases [17, 18] . In this study, however, it is impossible to evaluate it precisely and, at least, evidence suggesting the gender-specific susceptibility was not found. For example, the ratios of mother-children to father-children and parents-daughter to parents-son were 3.0 (180/60) and 4.6 (83/18), respectively, which were similar to the female/male ratio of the whole GD family, 3.2 (360/114). It is well recognized that both GD and HT are frequently found in members of the same family, implying a shared genetic predisposition [19, 20] . In the present study, approximately 8% of familial GD patients had HT in their first-degree relatives, supporting the existence of shared genes. Also, GD is often associated with other autoimmune or allergic disorders, and may be part of an autoimmune polyglandular syndrome. In fact, 7-9% of familial GD were associated with such disorders as type 1 diabetes, atopic dermatitis, asthma, rheumatoid arthritis and so on. Clinical features and laboratory findings were similar to those of non-familial GD. Most patients possessed goiter and approximately one-third had ophthalmopathy. Severe exophthalmos (³17 mm) and diplopia, which are typical characteristics of malignant ophthalmopathy, were found in 10-25% of patients *: includes unanswered **: since a significant number of patients did not provide information on questions, percentages were calculated by using both the total number (% of total) and the number of patients who provided clear information (% of answered). N/A: not applicable % of total and % of answered were same as Table 4 with orbitopathy. Most patients exhibited hyperthyroidism and positive TBII activities. Approximately 75% were positive for MCHA. Concerning treatment and prognosis of familial GD, there appeared to be no distinct difference from those of non-familial GD [21] . ATD, in which MMI was dominantly used, was the treatment of choice, and radioisotope or surgery was generally not regarded as a primary therapy. The frequencies of various side effects of ATD were considered within ordinary limits [22] .
In conclusion, we conducted a nationwide epidemiologic survey of familial GD and found an increased relative risk of familial GD within the proband's firstdegree relatives. This finding demonstrated the famil- *One of two drugs was used first, but was changed to the other due to side effects. **: euthyroid was maintained by administration of small doses (Small dose) or large doses (Resistant) of ATD. ***: there were five cases who had two complications. % of total and % of answered were same as Table 4 .
ial clustering of GD in the Japanese population, with evidence for the involvement of environmental factors, genetic factors or both in the pathogenesis of the disease.
